Chronic Liver Disease (CLD) | Hepatitus C (HCV) | Hepatitus B (HBV)

Hepatitius C and B
The First and ONLY Independent FibroScan Clinic in Arizona Open to the General Public - No Referrals Necessary.

Hepatitis C (HCV) - Hepatitis B (HBV)

Hepatitis C (HCV)
HCV is a growing problem in the US. With new, but expensive HCV anti-viral drugs on the market, some providers may limit short-term access based on need. FibroScan results may provide critical information that your Physician needs to know about the state of health of your liver.
HCV world-wide: Approximately 2%–3% (130–170 million) of the world's total population has been infected with HCV. In many developed countries, including the United States, the prevalence of HCV infection is <2%. The prevalence is higher (>2%) in several countries in Latin America, Eastern Europe, and the former Soviet Union, and certain countries in Africa, the Middle East, and South Asia; the prevalence is reported to be highest (>10%) in Egypt (9).
HCV US: US total population 319,140,000 with a 1-2% population prevalence percentage rate, approximately 2.7-5.2 million chronically infected by CDC, NHANES and expanded prevalence study (8) 8-10,000 deaths annually (10).
HCV AZ: Arizona total population 6,626,000 with 1-2% population prevalence percentage rate = the projected number of patients infected with HCV in the State of Arizona; or as many as 626,000 - 1,325,000 patients infected with HCV in the State of Arizona.
HCV Maricopa County: Maricopa County total population 4,009,412 with 1-2% population prevalence percentage rate = the projected number of patients with HCV infection in Maricopa County; or as many as 40,000 - 80,000 patients infected with HCV in Maricopa County.
Hepatitis B (HBV)
Hepatitis B is widespread in all parts of the globe, but especially in Asia. Approximately 20-25% of HBV patients progress to Liver Fibrosis/Liver Cirrhosis.
NASH world-wide: 3-5% of total population (5).
HBV world-wide:
In Asian countries like China and Japan Hepatitis B is at epidemic proportions. Currently there are 350 million persons infected with HBV globally – 75% in Asia. (10)
"The hepatitis B virus is a ubiquitous virus with a global distribution. Hepatitis B is one of the world's most common and serious infectious diseases. It is estimated that more than one third of the world's population has been infected with the hepatitis B virus." (9).
HBV US: 1.25 million persons infected (0.3%), 5-15% of Asian Americans, 4,000-5,000 deaths per year (10).
HBV AZ: Arizona population 6,626,000 with 0.3% population prevalence percentage rate = the projected number of patients with HCV infection in the State of Arizona; or as many as 19,800 patients infected with HBV in the State of Arizona.
HBV Maricopa County: Maricopa County population 4,009,412 with 0.3% population prevalence percentage rate = the projected number of patients with HCV infection in Maricopa County; or as many as 12,000 patients infected with HBV in Maricopa County.

Click on an active banner for more about Chronic Liver Disease (CLD) ...

Now You Too Can Get Your Liver FibroScan Score!
Contact The LiverLab TODAY To Find Out How!
It's accurate, painless and takes just a few minutes with same day results!



Alimentary Pharmacology & Therapeutics Systematic Review The Epidemiology and Natural History of Non-alcoholic Fatty Liver Disease and Non-alcoholic Steatohepatitis in AdultsG. Vernon, A. Baranova, Z. M. Younossi

Aliment Pharmacol Ther. 2011;34(3):274-285.


World J Gastroenterol. Nov 14, 2014; 20(42): 15532–15538.

Published online Nov 14, 2014. doi: 10.3748/wjg.v20.i42.15532

Liver transplantation and non-alcoholic fatty liver disease

Petros Zezos and Eberhard L Renner

(3) Aliment Pharmacol Ther. 2011 Aug; 34(3):274-85. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Vernon G, Baranova A, Younossi ZM

(4) Gastroenterology. 2011 Jan; 140(1):124-31. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, Landt CL, Harrison SA

(5) J Clin Gastroenterol. 2006 Mar; 40 Suppl 1():S17-29. Pathophysiology of nonalcoholic steatohepatitis. McCullough AJ

(6) Gerontology 1987;33:380-7.Clinical features and prognosis of alcoholic liver disease in respect of advancing age. Potter J, James O.

(7) Liver Transplantation Volume 10, Issue 8, August 2004 Older age and liver transplantation: A review Rajesh N. Keswani, Aijaz Ahmed, Emmet B. Keeffe *Division of Gastroenterology and Hepatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA


HCV Epidemiology in the United States - Hepatitis C online


Center for Disease Control and Prevention – online


The Liver Foundation - online

(12) Hepatology. 2010 Feb;51(2):454-62. Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease. Wong VW1, Vergniol J, Wong GL, Foucher J, Chan HL, Le Bail B, Choi PC, Kowo M, Chan AW, Merrouche W, Sung JJ, de Lédinghen V.

The LiverLab, located in Scottsdale, Arizona, is currently the only independant Liver FibroScan lab facility in the Metro Phoenix region. In addition to Scottsdale and Phoenix, AZ, the LiverLab services patients from the entire Phoenix Metro area to include Tempe, AZ; Mesa, AZ; Gilbert and Chandler, AZ and Glendale, Peoria, Surprise and Sun City, Arizona as well as other cities.


© 2014 - 2017 The LiverLab - TheLiverLab.Com - All Rights Reserved